Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified ... Virtual Press Office (press release) ViroPharma Incorporated (NASDAQ: VPHM) today announced that data from the pivotal study for their orphan drug Plenadren® (hydrocortisone, modified release tablet) were published in the Journal of Clinical Endocrinology and Metabolism (JCEM), ... |
